KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Other Non-Current Assets (2016 - 2026)

Bio-Rad Laboratories has reported Other Non-Current Assets over the past 18 years, most recently at $102.8 million for Q1 2026.

  • Quarterly Other Non-Current Assets fell 0.87% to $102.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $102.8 million through Mar 2026, down 0.87% year-over-year, with the annual reading at $102.7 million for FY2025, 0.79% up from the prior year.
  • Other Non-Current Assets was $102.8 million for Q1 2026 at Bio-Rad Laboratories, roughly flat from $102.7 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $109.0 million in Q3 2025 and troughed at $92.9 million in Q1 2024.
  • The 5-year median for Other Non-Current Assets is $101.8 million (2022), against an average of $100.8 million.
  • The largest YoY upside for Other Non-Current Assets was 12.73% in 2022 against a maximum downside of 9.2% in 2022.
  • A 5-year view of Other Non-Current Assets shows it stood at $94.6 million in 2022, then increased by 0.32% to $94.9 million in 2023, then rose by 7.38% to $101.9 million in 2024, then rose by 0.79% to $102.7 million in 2025, then rose by 0.1% to $102.8 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Other Non-Current Assets are $102.8 million (Q1 2026), $102.7 million (Q4 2025), and $109.0 million (Q3 2025).